×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SEPN – septerna, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SEPN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/3
10:18 am
sepn
Septerna (SEPN) had its price target raised by Wells Fargo & Company from $28.00 to $48.00. They now have an "overweight" rating on the stock.
Low
Report
Septerna (SEPN) had its price target raised by Wells Fargo & Company from $28.00 to $48.00. They now have an "overweight" rating on the stock.
3/2
01:00 pm
sepn
Septerna (SEPN) had its price target raised by HC Wainwright from $35.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Septerna (SEPN) had its price target raised by HC Wainwright from $35.00 to $40.00. They now have a "buy" rating on the stock.
3/1
10:14 am
sepn
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy [Yahoo! Finance]
Low
Report
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy [Yahoo! Finance]
3/1
09:45 am
sepn
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
Low
Report
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
2/26
06:28 am
sepn
Septerna (SEPN) was upgraded by Zacks Research from "strong sell" to "hold".
Low
Report
Septerna (SEPN) was upgraded by Zacks Research from "strong sell" to "hold".
2/24
08:00 am
sepn
Septerna to Present at TD Cowen 46th Annual Health Care Conference
Medium
Report
Septerna to Present at TD Cowen 46th Annual Health Care Conference
2/10
04:05 pm
sepn
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2/10
08:00 am
sepn
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
Low
Report
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/4
07:01 pm
sepn
Form 4 Septerna, Inc. For: Mar 02 Filed by: Shaikhly Samira
Medium
Report
Form 4 Septerna, Inc. For: Mar 02 Filed by: Shaikhly Samira
3/2
04:36 pm
sepn
Form 144 Septerna, Inc. Filed by: Shaikhly Samira
Low
Report
Form 144 Septerna, Inc. Filed by: Shaikhly Samira
3/2
07:01 am
sepn
Form 8-K Septerna, Inc. For: Mar 01
Low
Report
Form 8-K Septerna, Inc. For: Mar 01
2/20
05:29 pm
sepn
Form 4 Septerna, Inc. For: Feb 18 Filed by: Bhatt Elizabeth
Low
Report
Form 4 Septerna, Inc. For: Feb 18 Filed by: Bhatt Elizabeth
2/18
04:27 pm
sepn
Form 144 Septerna, Inc. Filed by: Bhatt Elizabeth
Medium
Report
Form 144 Septerna, Inc. Filed by: Bhatt Elizabeth
2/17
04:26 pm
sepn
Form SCHEDULE 13G/A Septerna, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SCHEDULE 13G/A Septerna, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
2/10
07:17 pm
sepn
Form 4 Septerna, Inc. For: Feb 06 Filed by: Long Daniel D.
Low
Report
Form 4 Septerna, Inc. For: Feb 06 Filed by: Long Daniel D.
2/10
07:15 pm
sepn
Form 4 Septerna, Inc. For: Feb 06 Filed by: Klein Uwe
Low
Report
Form 4 Septerna, Inc. For: Feb 06 Filed by: Klein Uwe
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: